Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 50+ Global Mutual Funds
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Diversify into RBI-regulated P2P lending platforms and earn up to 11.5% p.a.
Invest in curated
corporate, gold, and govt. bonds
Earn income
while helping India move to clean energy
Connect with investors, share insights, and grow together.
Master the world of Alternative Investments with our in-depth courses
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the OTC pharmaceutical business in Hong Kong and Mainland China. It provides OTC pharmaceutical cross-border e-commerce supply chain; and procurement and distribution services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. Hong Kong Pharma Digital Technology Holdings Limited was incorporated in 2023 and is based in Yau Tong, Hong Kong. more
Time Frame | HKPD | S&P500 | |
---|---|---|---|
1-Week Return | 14.6%% | % | 4.65%% |
1-Month Return | -0.98%% | % | 12.32%% |
3-Month Return | -49.26%% | % | -3.48%% |
6-Month Return | -63.83%% | % | 0.38%% |
Mar '23 | Mar '24 | |||||
---|---|---|---|---|---|---|
Total Revenue | 12.56M | 16.69M | [{"date":"2023-03-31","value":75.24,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Cost of Revenue | 9.82M | 13.13M | [{"date":"2023-03-31","value":74.77,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Gross Profit | 2.74M | 3.56M | [{"date":"2023-03-31","value":76.96,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Gross Margin | 21.81% | 21.32% | [{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":97.76,"profit":true}] | |||
Operating Expenses | 11.48M | 15.02M | [{"date":"2023-03-31","value":76.45,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Operating Income | 1.08M | 1.67M | [{"date":"2023-03-31","value":64.37,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Non-Operating Income/Expense | (56.30K) | (147.28K) | [{"date":"2023-03-31","value":-5630400,"profit":false},{"date":"2024-03-31","value":-14727900,"profit":false}] | |||
Pre-Tax Income | 1.02M | 1.53M | [{"date":"2023-03-31","value":66.89,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Income Taxes | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Income After Taxes | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Income From Continuous Operations | 998.20K | 1.33M | [{"date":"2023-03-31","value":75.07,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Income From Discontinued Operations | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Net Income | 998.20K | 1.33M | [{"date":"2023-03-31","value":75.07,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
EPS (Diluted) | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Mar '23 | Mar '24 | |||||
---|---|---|---|---|---|---|
Total Revenue | - | 32.91% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Cost of Revenue | - | 33.74% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Gross Profit | - | 29.93% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Gross Margin | - | (2.24%) | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false}] | |||
Operating Expenses | - | 30.81% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Operating Income | - | 55.35% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Non-Operating Income/Expense | - | 161.58% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Pre-Tax Income | - | 49.49% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Income Taxes | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Income After Taxes | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Income From Continuous Operations | - | 33.21% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Income From Discontinued Operations | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Net Income | - | 33.21% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
EPS (Diluted) | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Total Revenue | [] | |||||
Cost of Revenue | [] | |||||
Gross Profit | [] | |||||
Gross Margin | [] | |||||
Operating Expenses | [] | |||||
Operating Income | [] | |||||
Total Non-Operating Income/Expense | [] | |||||
Pre-Tax Income | [] | |||||
Income Taxes | [] | |||||
Income After Taxes | [] | |||||
Income From Continuous Operations | [] | |||||
Income From Discontinued Operations | [] | |||||
Net Income | [] | |||||
EPS (Diluted) | [] | |||||
Total Revenue | [] | |||||
Cost of Revenue | [] | |||||
Gross Profit | [] | |||||
Gross Margin | [] | |||||
Operating Expenses | [] | |||||
Operating Income | [] | |||||
Total Non-Operating Income/Expense | [] | |||||
Pre-Tax Income | [] | |||||
Income Taxes | [] | |||||
Income After Taxes | [] | |||||
Income From Continuous Operations | [] | |||||
Income From Discontinued Operations | [] | |||||
Net Income | [] | |||||
EPS (Diluted) | [] | |||||
Mar '23 | Mar '24 | |||||
---|---|---|---|---|---|---|
Total Assets | ||||||
Current Assets | 2.75M | 7.80M | [{"date":"2023-03-31","value":35.23,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Non-current Assets | 658.29K | 865.52K | [{"date":"2023-03-31","value":76.06,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Assets | 3.41M | 8.67M | [{"date":"2023-03-31","value":39.31,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Liabilities | ||||||
Current Liabilities | 2.55M | 3.18M | [{"date":"2023-03-31","value":80.28,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Non-current Liabilities | 271.45K | 1.24M | [{"date":"2023-03-31","value":21.94,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Liabilities | 2.82M | 4.41M | [{"date":"2023-03-31","value":63.93,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Shareholders' equity | ||||||
Common Stock | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Retained Earnings | 201.39K | 1.53M | [{"date":"2023-03-31","value":13.15,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Other Stockholders' Equity | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Total Shareholders' equity | 585.24K | 4.25M | [{"date":"2023-03-31","value":13.76,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Liabilities & Shareholders Equity | 3.41M | 8.67M | [{"date":"2023-03-31","value":39.31,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Mar '23 | Mar '24 | |||||
---|---|---|---|---|---|---|
Total Assets | ||||||
Current Assets | - | 183.86% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Non-current Assets | - | 31.48% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Assets | - | 154.41% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Liabilities | ||||||
Current Liabilities | - | 24.56% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Non-current Liabilities | - | 355.74% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Liabilities | - | 56.43% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Shareholders' equity | ||||||
Common Stock | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Retained Earnings | - | 660.27% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Other Stockholders' Equity | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Total Shareholders' equity | - | 626.82% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Liabilities & Shareholders Equity | - | 154.41% | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |||
Total Assets | ||||||
Current Assets | [] | |||||
Non-current Assets | [] | |||||
Total Assets | [] | |||||
Total Liabilities | ||||||
Current Liabilities | [] | |||||
Non-current Liabilities | [] | |||||
Total Liabilities | [] | |||||
Total Shareholders' equity | ||||||
Common Stock | [] | |||||
Retained Earnings | [] | |||||
Other Stockholders' Equity | [] | |||||
Total Shareholders' equity | [] | |||||
Total Liabilities & Shareholders Equity | [] | |||||
Total Assets | ||||||
Current Assets | [] | |||||
Non-current Assets | [] | |||||
Total Assets | [] | |||||
Total Liabilities | ||||||
Current Liabilities | [] | |||||
Non-current Liabilities | [] | |||||
Total Liabilities | [] | |||||
Total Shareholders' equity | ||||||
Common Stock | [] | |||||
Retained Earnings | [] | |||||
Other Stockholders' Equity | [] | |||||
Total Shareholders' equity | [] | |||||
Total Liabilities & Shareholders Equity | [] | |||||
Mar '23 | Mar '24 | |||||
---|---|---|---|---|---|---|
Operating Activities | ||||||
Net Operating Cash Flow | 1.73M | (394.33K) | [{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-22.83,"profit":false}] | |||
Investing Activities | ||||||
Net Investing Cash Flow | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Financing Activities | ||||||
Net Financing Cash Flow | (1.16M) | 537.32K | [{"date":"2023-03-31","value":-215.08,"profit":false},{"date":"2024-03-31","value":100,"profit":true}] | |||
Net Change in Cash | 439.63K | 102.64K | [{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":23.35,"profit":true}] | |||
Free Cash Flow | ||||||
Free Cash Flow | 1.61M | (482.35K) | [{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-29.97,"profit":false}] | |||
Mar '23 | Mar '24 | |||||
---|---|---|---|---|---|---|
Operating Activities | ||||||
Net Operating Cash Flow | - | (122.83%) | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false}] | |||
Investing Activities | ||||||
Net Investing Cash Flow | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |||
Financing Activities | ||||||
Net Financing Cash Flow | - | (146.49%) | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false}] | |||
Net Change in Cash | - | (76.65%) | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false}] | |||
Free Cash Flow | ||||||
Free Cash Flow | - | (129.97%) | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false}] | |||
Operating Activities | ||||||
Net Operating Cash Flow | [] | |||||
Investing Activities | ||||||
Net Investing Cash Flow | [] | |||||
Financing Activities | ||||||
Net Financing Cash Flow | [] | |||||
Net Change in Cash | [] | |||||
Free Cash Flow | ||||||
Free Cash Flow | [] | |||||
Operating Activities | ||||||
Net Operating Cash Flow | [] | |||||
Investing Activities | ||||||
Net Investing Cash Flow | [] | |||||
Financing Activities | ||||||
Net Financing Cash Flow | [] | |||||
Net Change in Cash | [] | |||||
Free Cash Flow | ||||||
Free Cash Flow | [] | |||||
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
HKPD | |
---|---|
ROA (LTM) | 0.00% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
HKPD | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.00 |
EV/R | 0.00 |
EV/Ebitda | NM |
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) share price today is $1.0199
Yes, Indians can buy shares of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) on Vested. To buy Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HKPD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) via the Vested app. You can start investing in Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) with a minimum investment of $1.
You can invest in shares of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) via Vested in three simple steps:
The 52-week high price of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is $3.79. The 52-week low price of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is $0.81.
The price-to-book (P/B) ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is 0.00
The market capitalization of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is $9.79M
The stock symbol (or ticker) of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares is HKPD